SPRINGDALE, Ark., June 16, 2021 /PRNewswire/ — The University of Arkansas and NOWDiagnostics, Inc., a Springdale-based leader in innovative diagnostics testing, announced today an active partnership to study the prevalence of SARS-CoV-2 virus antibodies among University of Arkansas (U of A) students, staff and faculty. The ADEXUSDx® COVID-19 Test is a rapid serology, self-contained assay […]
SPRINGDALE, AR, May 26, 2021 – NOWDiagnostics, Inc. announced today that it has received Emergency Use Authorization (EUA) for its ADEXUSDx® COVID-19 antibody test for use at the point-of-care from the U.S. Food and Drug Administration (FDA). Following the EUA, NOWDiagnostics will begin offering the ADEXUSDx® COVID-19 antibody test for use across a variety of CLIA-waived
NEW YORK — The US Food and Drug Administration has granted separate Emergency Use Authorizations for a molecular SARS-CoV-2 test developed by Harvard University and a point-of-care immunoassay for the virus from NowDiagnostics. Harvard’s Quaeris SARS-CoV-2 Assay is designed to detect the virus’s N and RdRP genes in anterior nasal swab specimens either self-collected or
Monday, August 31, 2020 SPRINGDALE, AR, August 31, 2020 – NOWDiagnostics, Inc. announced today it is working with BARDA, the Biomedical Advanced Research and Development Authority arm of the U.S. Department of Health and Human Services, to develop a serological test for SARS-CoV-2 antibodies that can be used across a variety of health care settings—from clinics
ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval We are proud to announce that our ADEXUSDx COVID-19 antibody test has received Conformité Européene (CE) mark approval across 28 countries in the EU. With CE approval, our antibody test will be available in a variety of healthcare centers such as clinics and hospital emergency rooms.
ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval Read More »
Introducing the ADEXUSDx COVID-19 Test At NOWDiagnostics, we’re always looking for ways to respond to community needs. Our new, rapid ADEXUSDx COVID-19 serology antibody test will be essential to America’s recovery from COVID-19, as we believe it can assist with vaccine development and contact tracing. Interested in learning more? You can read the full article
Introducing the ADEXUSDx COVID-19 Test Read More »
NOWDx seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test The ADEXUSDx® COVID-19 Test is a rapid serology test that detects total antibodies to SARS-CoV-2. It provides in-field, lab accurate results within 15 minutes, using as little as a drop of blood. The test does not require buffers or reagents, lab equipment, refrigeration, or in demand ancillary
NOWDiagnostics seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test Read More »
Copyright © 2020 – NOWDiagnostics.